Pharmaceutical definition

Cross-linked versions of water-soluble polymers swollen in aqueous media are broadly referred to as hydrogels (52) and have a growing commercial utility in such apphcations as oxygen-permeable soft contact lenses (qv) (53) (Table 4) and controUed-release pharmaceutical dmg deflvery devices (54). Cross-linked PVP and selected copolymers fit this definition and are of interest because of the following stmcture/performance characteristics ... 

To avoid confusion, several researchers have incorporated therapeutic intention into the definition of controlled release (4—7). Thus, controUed-release pharmaceuticals release dmgs in vivo according to a predictable, therapeutically rational, programmed rate to achieve the optimal dmg concentration in the minimal time (4). Specification by release rate complements specification by quantity jointly considered, they fix the duration of dmg release. Therefore, the dmg s duration of action can become a design property of a controlled release dosage form rather than an inherent pharmacokinetic property of the dmg molecule. 

Control of metalloid content in natural objects, foodstuff and pharmaceuticals is an important task for modern analytical chemistry. Determination of elements such as Arsenic is necessary for evaluation of object toxicity, since their content in environment may exceed MCL (maximum contaminant level), posing hazard to human health. Elements such as Selenium in definite doses are healthy, but in greater quantities they produce toxic effect. 

Where is the dividing line between bulk and fine chemicals Here again there is no universally accepted definition. Nonetheless, a useful definition of a fine chemical is one with a price of more than 10 US dollars/kg and a volume of less than 10,000 tons per annum. The latter is rather a large volume for most fine chemicals, e.g. most pharmaceutical intermediates are produced in quantities of less than 100 tons per annum. In practice, the type of technology used is probably more dictated by volume than by product application. 

A general definition of log P and log D, in its simplest form, can be given as the logarithm of the ratio (P or D) of the concentration of species of interest (the drug in a pharmaceutical context) in each phase, assuming the phases are immiscible and well separated prior to analysis. P is defined as the partition coefficient, whereas D is the distribution coefficient. However, the simplest form does not reveal some of the intricacies of the determination and use of these parameters, and further explanation is necessary. 

Since the final product is a pharmaceutical, high purity of the product is definitely required. Furthermore, the amount of any impurities in the final product has to be rigorously regulated under ICH guidelines. Rejection of impurities related to cyclopropylacetylene (37) was difficult throughout this whole process [28]. Thus, not only the isolated yield but the impurity profile of 37 was critical. 

A disperse system is defined as a heterogenous, two-phase system in which the internal (dispersed, discontinuous) phase is distributed or dispersed within the continuous (external) phase or vehicle. Various pharmaceutical systems are included in this definition, the internal and external phases being gases, liquids, or solids. Disperse systems are also important in other fields of application, e.g., processing and manufacturing of household and industrial products such as cosmetics, foods, and paints. 

Equation (1) points to a number of important particle properties. Clearly the particle diameter, by any definition, plays a role in the behavior of the particle. Two other particle properties, density and shape, are of significance. The shape becomes important if particles deviate significantly from sphericity. The majority of pharmaceutical aerosol particles exhibit a high level of rotational symmetry and consequently do not deviate substantially from spherical behavior. The notable exception is that of elongated particles, fibers, or needles, which exhibit shape factors, kp, substantially greater than 1. Density will frequently deviate from unity and must be considered in comparing aerodynamic and equivalent volume diameters. 

Packaging that is developed according to patient education principals can serve as a strong reminder or motivational aid to the patient. The complete package, a new concept recently proposed, is the most advanced type of compliance packaging. The proponents of this concept recommend that pharmaceutical companies expand their definition of a product beyond that of the medication. The complete package consists of the medication plus the complete set of compliance packaging and the educational materials necessary to help the patient obtain the desired therapeutic outcome. 

The purpose of this chapter is to present the main economic characteristics of reference pricing (RP) as a system for the public funding of pharmaceuticals financed by the public sector. The following sections deal with the definition and objectives of RP and analyse the features of the various reference pricing systems that are applied internationally. This is followed by a look at the justification for RP from the economic point of view. We then go on to analyse the impact of RP policies, especially with regard to expenditure, consumption and drag prices. In the final section we discuss what can be expected from the application of RP to the Spanish health system. 

A classic pharmaceutical science textbook might have defined poor solubility as anything below a solubility of 1 g mL-1 (2 mol L-1 solution for a molecular weight of 500 Da) at pH 6.5 (or pH 7). This classic view is reflected in the Chemical Abstracts SciFinder 2001 solubility range definitions for solubility calculated using Advanced Chemistry Development (ACD) Software Solaris V4.67. These semi-quantitative ranges for molar solubility are very soluble, 1 mol L 1 < solubility soluble, 0.1 mol L 1 < solubility < 1 mol L 1 slightly soluble, 0.01 mol L 1 <... 

---